200 related articles for article (PubMed ID: 26656684)
1. Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.
Elsebai MF; Koutsoudakis G; Saludes V; Pérez-Vilaró G; Turpeinen A; Mattila S; Pirttilä AM; Fontaine-Vive F; Mehiri M; Meyerhans A; Diez J
J Virol; 2016 Feb; 90(4):1918-30. PubMed ID: 26656684
[TBL] [Abstract][Full Text] [Related]
2. The wild Egyptian artichoke as a promising functional food for the treatment of hepatitis C virus as revealed via UPLC-MS and clinical trials.
Elsebai MF; Abass K; Hakkola J; Atawia AR; Farag MA
Food Funct; 2016 Jul; 7(7):3006-16. PubMed ID: 27296047
[TBL] [Abstract][Full Text] [Related]
3. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
4. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
[TBL] [Abstract][Full Text] [Related]
6. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative Effects of Cynara cardunculus L. var. altilis (DC) Lipophilic Extracts.
Ramos PA; Guerra ÂR; Guerreiro O; Santos SA; Oliveira H; Freire CS; Silvestre AJ; Duarte MF
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036090
[TBL] [Abstract][Full Text] [Related]
8. Methanolic Extract of
Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.
Wahyuni TS; Tumewu L; Permanasari AA; Apriani E; Adianti M; Rahman A; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Nasronudin ; Fuchino H; Kawahara N; Shoji I; Deng L; Aoki C; Hotta H
Virol J; 2013 Aug; 10():259. PubMed ID: 24089993
[TBL] [Abstract][Full Text] [Related]
10. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
[TBL] [Abstract][Full Text] [Related]
11. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
[TBL] [Abstract][Full Text] [Related]
12. Antispasmodic activity of fractions and cynaropicrin from Cynara scolymus on guinea-pig ileum.
Emendörfer F; Emendörfer F; Bellato F; Noldin VF; Cechinel-Filho V; Yunes RA; Delle Monache F; Cardozo AM
Biol Pharm Bull; 2005 May; 28(5):902-4. PubMed ID: 15863902
[TBL] [Abstract][Full Text] [Related]
13. Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
Galani BR; Sahuc ME; Sass G; Njayou FN; Loscher C; Mkounga P; Deloison G; Brodin P; Rouillé Y; Tiegs G; Séron K; Moundipa PF
Arch Virol; 2016 May; 161(5):1169-81. PubMed ID: 26843184
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis of the germacrene A synthase gene and association with cynaropicrin content and biological activities in Cynara cardunculus.
Ferro AM; Ramos P; Guerra Â; Parreira P; Brás T; Guerreiro O; Jerónimo E; Capel C; Capel J; Yuste-Lisbona FJ; Duarte MF; Lozano R; Oliveira MM; Gonçalves S
Mol Genet Genomics; 2018 Apr; 293(2):417-433. PubMed ID: 29143866
[TBL] [Abstract][Full Text] [Related]
15. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
[TBL] [Abstract][Full Text] [Related]
16. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
[TBL] [Abstract][Full Text] [Related]
17. Sesquiterpene Lactones from Cynara cornigera: Acetyl Cholinesterase Inhibition and In Silico Ligand Docking.
Hegazy ME; Ibrahim AY; Mohamed TA; Shahat AA; El Halawany AM; Abdel-Azim NS; Alsaid MS; Paré PW
Planta Med; 2016 Jan; 82(1-2):138-46. PubMed ID: 26441064
[TBL] [Abstract][Full Text] [Related]
18. Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action.
Shimoda H; Ninomiya K; Nishida N; Yoshino T; Morikawa T; Matsuda H; Yoshikawa M
Bioorg Med Chem Lett; 2003 Jan; 13(2):223-8. PubMed ID: 12482428
[TBL] [Abstract][Full Text] [Related]
19. Deep Eutectic Solvents as Efficient Media for the Extraction and Recovery of Cynaropicrin from Cynara cardunculus L. Leaves.
de Faria ELP; do Carmo RS; Cláudio AFM; Freire CSR; Freire MG; Silvestre AJD
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29084184
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
